1. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement
- Author
-
Omer Azal, Mahmut Ilker Yilmaz, Serkan Tapan, Abdullah Taslipinar, Erol Bolu, Aydogan Aydogdu, Mustafa Dinc, Alper Sonmez, Kamil Baskoy, Yalcin Basaran, Cem Haymana, Cem Barçın, Mahmut Yazici, and Coskun Meric
- Subjects
Adult ,Blood Glucose ,Male ,medicine.medical_specialty ,Hormone Replacement Therapy ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Population ,Body Mass Index ,Young Adult ,chemistry.chemical_compound ,Endocrinology ,Insulin resistance ,Risk Factors ,Internal medicine ,medicine ,Humans ,Insulin ,Testosterone ,Endothelial dysfunction ,education ,Triglycerides ,Inflammation ,education.field_of_study ,biology ,business.industry ,Hypogonadism ,C-reactive protein ,medicine.disease ,Treatment Outcome ,chemistry ,biology.protein ,Homeostatic model assessment ,Endothelium, Vascular ,Insulin Resistance ,Waist Circumference ,business ,Asymmetric dimethylarginine ,Hypogonadotrophic hypogonadism - Abstract
Patients with hypogonadism have poor cardiovascular and metabolic outcomes, and the effect of testosterone replacement therapy (TRT) is not clear. We investigated the presence of inflammation, insulin resistance and endothelial dysfunction in an unconfounded population of congenital hypogonadotrophic hypogonadism (CHH) and the effect of TRT on these subjects. A total of 60 patients with CHH (mean age 21.82±2.22 years) and 70 healthy control subjects (mean age 21.32±1.13 years) were enrolled. The demographic parameters, Asymmetric dimethylarginine (ADMA), TNF-like weak inducer of apoptosis (TWEAK), high sensitive C reactive protein (hs-CRP) and homeostatic model assessment of insulin resistance (HOMA-IR) levels were measured before and after TRT. The patients had higher Waist Circumferences (WC) (p=0.009), Diastolic Blood Pressures (p=0.02), Triglycerides (p=0.03), ADMA, insulin and HOMA-IR levels (p
- Published
- 2015